Industry Experience:
Advance corporate vision and create regulatory strategies for industry leaders in heavily regulated industries (domestic and global); advise CEOs/senior leadership, create strategies and communication plans that build reputations, advance pipelines and fulfill missions.
Health Care: Biotechnology, pharmaceuticals, medtech, health insurance/managed care, top industry trade groups, patient advocacy, investment community
Expertise:
- Regulatory policy and strategy
- Reimbursement strategy
- Intersection of industry and public policy
- External and advocacy relations
- Government Affairs
- Communications
- Strategic engagement plans
Government Experience: Senior positions at the Food and Drug Administration; Legal position at the Centers for Medicare and Medicaid Services (then HCFA); Congressional staff – Legislative aid to a Member of the House Energy and Commerce Committee
Functional Experience:
Founder and leader of a successful consulting firm for the past 8 years; work with CEOs and other top executives, providing strategic advice and competitive intelligence. Clients range from:
- Small startup medical device companies with disruptive technologies
- A $58 billion (sales) Top 5 global pharmaceutical company
- An investment firm that has launched 20+ biotech companies in the past 5 years
Key Business Transactional Experience:
President of a thriving small business; Lawyer and negotiator; Past President of an effective growing non-profit coalition – served as one of the original four people who launched the coalition, and within a year, Ms. Myers was a major player in orchestrating and negotiating the seamless and successful merger with a like organization
What is the most important skill you bring to a corporate board?
Nancy Myers brings a deep understanding of strategies to advance the bottom line of heavily regulated companies. She brings particular expertise in harnessing government policy and regulatory dynamics, and expanding necessary circles of influence. Ms. Myers is a sought-after public speaker and lecturer, and is often called upon to comment in the press on regulatory developments.
